首页 > 市场调查报告书 > 医疗设备

药物递输设备

智慧胰岛素笔市场规模、份额、成长分析（按类型、易用性、产品类型、连接类型、适应症、最终用户和地区划分）—产业预测（2026-2033年）

市场调查报告书

商品编码

1898680

智慧胰岛素笔市场规模、份额、成长分析（按类型、易用性、产品类型、连接类型、适应症、最终用户和地区划分）—产业预测（2026-2033年）

Smart Insulin Pens Market Size, Share, and Growth Analysis, By Type (First Generation Pens, Second Generation Pens), By Usability, By Product, By Connectivity Type, By Indication, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，智慧胰岛素笔市场规模将达到 49.6 亿美元，到 2025 年将成长至 54.7 亿美元，到 2033 年将成长至 119.9 亿美元，在预测期（2026-2033 年）内，复合年增长率为 10.3%。

智慧胰岛素笔的出现，标誌着糖尿病管理领域的一项重大进步，它简化了糖尿病患者体外注射胰岛素的流程。这些创新设备具备及时提醒和警报功能，鼓励患者规律用药，并因其易用性而日益普及。智慧胰岛素笔可与现有的胰岛素输注系统无缝连接，密切监测漏服剂量，确保剂量准确。透过定时血糖值监测、温度控制和药物有效期管理等功能，智慧胰岛素笔得以维护详细的糖尿病檔案，从而保障患者的健康。儘管外部因素对市场成长构成挑战，但对便利高效的1型和第2型糖尿病管理解决方案的需求，仍持续推动智慧胰岛素笔市场的扩张。

智慧胰岛素笔市场驱动因素

糖尿病患者人数的增加主要是由于现代社会的快速变化以及年轻一代日益沉重的负担。患者人数的激增显着提高了对胰岛素产品的需求，其中智慧胰岛素笔尤其备受关注。由于快节奏的生活方式使得血糖值控制和胰岛素剂量调整变得困难，智慧技术已成为应对这些挑战的有效解决方案。此外，人们对针刺伤的日益重视也进一步推动了对这些创新设备的需求，促使製造商扩大生产规模，以抓住这项盈利的市场机会。

限制智慧胰岛素笔市场发展的因素

智慧胰岛素笔的高昂价格可能会抑制其在全球市场的需求。在发展中地区，尤其是在非洲，许多病患由于医疗资源匮乏和报销政策不合理而面临许多挑战。这些因素阻碍了他们获得必要的医疗服务以及使用智慧胰岛素笔等先进技术。因此，高成本加上支援不足，可能会对最需要这些创新设备的患者获得和使用产生重大影响，最终阻碍市场成长，并限製糖尿病患者从中受益。

智慧胰岛素笔市场趋势

智慧胰岛素笔市场正呈现显着成长趋势，这主要得益于医疗研发的不断进步以及全球糖尿病患者数量的持续成长。随着对创新型糖尿病管理解决方案的需求日益增长，製造商不断推出旨在改善患者体验并提高胰岛素治疗依从性的尖端产品。此外，连接性和剂量追踪等技术的整合对于满足糖尿病患者的复杂需求至关重要。这些技术创新，加上不断增长的市场需求，为智慧胰岛素笔市场创造了巨大的发展机会，预计该市场在不久的将来将保持强劲成长。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Novo Nordisk A/S（Denmark）
Eli Lilly and Company（USA）
Medtronic plc（Ireland）
BD（Becton, Dickinson and Company）（USA）
Ypsomed Holding AG（Switzerland）
Companion Medical（USA）
Digital Medics Pty Ltd（Australia）
Biocorp（France）
Emperra GmbH（USA）
E-Health Technologies（Germany）
Bigfoot Biomedical, Inc.（USA）
Hoffmann-La Roche AG（Switzerland）
Tandem Diabetes Care, Inc.（USA）
Insulet Corporation（USA）
Abbott Laboratories（USA）
Terumo Corporation（Japan）
Owen Mumford Ltd.（UK）
SOOIL Development Co., Ltd.（South Korea）
Pendiq GmbH（Germany）
DarioHealth Corp.（Israel）

结论与建议

简介目录

Product Code: SQMIG35A2194

Smart Insulin Pens Market size was valued at USD 4.96 Billion in 2024 and is poised to grow from USD 5.47 Billion in 2025 to USD 11.99 Billion by 2033, growing at a CAGR of 10.3% during the forecast period (2026-2033).

Smart insulin pens represent a significant advancement in diabetes management by facilitating the external administration of insulin for diabetic patients. These innovative devices feature timely reminders and alerts that encourage regular dosing, enhancing usability and growing in popularity. Smart insulin pens can seamlessly attach to existing insulin delivery systems, providing critical monitoring of missed doses and ensuring accurate dosage administration. Their ability to maintain a detailed diabetes profile by tracking levels at designated times and ensuring temperature compliance and medication expiry safeguards patient health. Although there have been challenges affecting market growth due to external factors, the demand for convenient and efficient solutions in managing both type 1 and type 2 diabetes continues to propel the expansion of the smart insulin pen market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Smart Insulin Pens market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Smart Insulin Pens Market Segments Analysis

Global Smart Insulin Pens Market is segmented by Type, Usability, Product, Connectivity Type, Indication, End User and region. Based on Type, the market is segmented into First Generation Pens and Second Generation Pens. Based on Usability, the market is segmented into Prefilled and Reusable. Based on Product, the market is segmented into Smart Insulin Pen and Adaptors for Conventional Pen. Based on Connectivity Type, the market is segmented into Bluetooth and USB. Based on Indication, the market is segmented into Type 1diabetesand Type 2 Diabetes. Based on End User, the market is segmented into Hospitals and Clinics, Ambulatory Surgical Centers and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Smart Insulin Pens Market

The rise in the number of individuals with diabetes is largely attributed to the fast-paced nature of modern society and the increasing demands placed on younger generations. This surge in diabetic patients has led to a significant uptick in the demand for insulin products, among which smart insulin pens have gained notable popularity. As people's hectic lifestyles make it challenging to monitor diabetes readings and manage insulin dosing effectively, smart technology has emerged as a valuable solution to address these issues. Additionally, the growing awareness of needle stick injuries has further contributed to the demand for these innovative devices, prompting manufacturers to ramp up production in a bid to capitalize on this lucrative market opportunity.

Restraints in the Smart Insulin Pens Market

The elevated pricing of smart insulin pens is likely to hinder their demand in the global market. Many patients in developing regions, particularly in Africa, are facing challenges due to limited healthcare resources and unfavorable reimbursement policies. These conditions discourage individuals from pursuing necessary medical treatments or utilizing advanced technologies, like smart insulin pens. As a result, the combination of high costs and inadequate support systems may significantly impact the accessibility and adoption of these innovative devices for those who need them most, ultimately stymying market growth and limiting the benefits they offer to diabetic patients.

Market Trends of the Smart Insulin Pens Market

The smart insulin pens market is witnessing a significant trend driven by ongoing advancements in research and development within the healthcare sector, alongside the rising prevalence of diabetes globally. As the demand for innovative diabetes management solutions increases, manufacturers are launching cutting-edge products designed to enhance patient experience and adherence to insulin regimens. Furthermore, the integration of technology, such as connectivity features and dose tracking, is becoming essential in addressing the complex needs of diabetic patients. This convergence of innovation and growing market demand presents substantial opportunities for expansion, positioning the smart insulin pens market for robust growth in the foreseeable future.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Smart Insulin Pens Market Size by Type & CAGR (2026-2033)

Market Overview
First Generation Pens
Second Generation Pens

Global Smart Insulin Pens Market Size by Usability & CAGR (2026-2033)

Market Overview
Prefilled
Reusable

Global Smart Insulin Pens Market Size by Product & CAGR (2026-2033)

Market Overview
Smart Insulin Pen
Adaptors for Conventional Pen

Global Smart Insulin Pens Market Size by Connectivity Type & CAGR (2026-2033)

Market Overview
Bluetooth
USB

Global Smart Insulin Pens Market Size by Indication & CAGR (2026-2033)

Market Overview
Type 1 Diabetes
Type 2 Diabetes

Global Smart Insulin Pens Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals and Clinics
Ambulatory Surgical Centers
Home Care Settings

Global Smart Insulin Pens Market Size & CAGR (2026-2033)

North America (Type, Usability, Product, Connectivity Type, Indication, End User)
- US
- Canada
Europe (Type, Usability, Product, Connectivity Type, Indication, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Usability, Product, Connectivity Type, Indication, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Usability, Product, Connectivity Type, Indication, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Usability, Product, Connectivity Type, Indication, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Novo Nordisk A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Companion Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Digital Medics Pty Ltd (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocorp (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emperra GmbH (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
E-Health Technologies (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bigfoot Biomedical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tandem Diabetes Care, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Insulet Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Owen Mumford Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SOOIL Development Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pendiq GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DarioHealth Corp. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments